Opaleye Management Inc.

Reported to SECin USFilings at 4 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 50. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 50
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Grace Therapeutics, Inc.—Open-market buy$16,4047,849 sharesOct 1, 2026Grace Therapeutics, Inc.$16,404Buy · Oct 1Open-market buy7,849Oct 1, 2026
Grace Therapeutics, Inc.—Open-market buy$11,1685,318 sharesOct 1, 2026Grace Therapeutics, Inc.$11,168Buy · Oct 1Open-market buy5,318Oct 1, 2026
Grace Therapeutics, Inc.—Open-market buy$20,5199,771 sharesOct 1, 2026Grace Therapeutics, Inc.$20,519Buy · Oct 1Open-market buy9,771Oct 1, 2026
Alpha Cognition Inc.—Open-market buy$113,71813,426 sharesSep 28, 2026Alpha Cognition Inc.$113,718Buy · Sep 28Open-market buy13,426Sep 28, 2026
Alpha Cognition Inc.—Open-market buy$157,08218,337 sharesSep 28, 2026Alpha Cognition Inc.$157,082Buy · Sep 28Open-market buy18,337Sep 28, 2026